Products
The PrIME process is the only
disposable plasma fractionation system available. This allows for the complete removal of CIP
costs. These costs represent at least
20% of the general COGS for the existing fractionators. It is also the main area of concern for the
regulators, as any failure in CIP can lead to virus etc passing from one
production batch to the next. By using
the PrIME process the Singapore Company will be able to process plasma from all
of ASEAN/China/India. Much of this
plasma is Currently Unprocessable Plasma
referred to above and is thrown away as the regulators in the countries in
which the fractionators operate will not allow plasma from these countries to
be processed in their plants. The
regulators fear that the CIP will not remove some contaminates from the Currently Unprocessable Plasma leading
to contamination of their home Therapeutic Plasma products. Again this is not an issue when using the
PrIME process.
Contact
For more information regarding PrIME Biologics' products, please contact us on +612 8415 7300 or email us at info@nusep.com.
